Aalto Bio Reagents Ltd.

One of the longest, established, privately held biotech companies, founded in 1978. Leading global provider of high-quality raw materials to the in-vitro diagnostic industry and research laboratories. ISO 13485:2016 registered. First to market proteins and monoclonal antibodies for the new emerging viruses, eg. Dengue, Chikungunya and Zika, Sars, Covid -19 and VEEV virus. Wide range of well-established products for chemiluminscence, ELISA, lateral flow and other immunoassay formats. Custom manufacture of antibodies and recombinant antigens under ISO 13485:2016 conditions.